ArticleLeukemia2024

Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy.

Eduardo Sabino de Camargo Magalhães et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.